PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsretinal neovascularization
MeSH D015861 - retinal neovascularization
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012164:Retinal diseases
$
Success rate
D009389:Pathologic neovascularization
0 Companies
0 Drugs
Success rate
D015861: 
Retinal neovascularization
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
60%
6/10
Phase 3
40%
2/5
Approved: 0Overall Success rate: 12%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use